Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
Among patients with severe antineutrophil cytoplasmic antibody–associated vasculitis, plasma exchange did not reduce the incidence of death or end-stage kidney disease. A reduced-dose regimen of oral glucocorticoids was noninferior to a standard-dose regimen with respect to death or ESKD.
Saved in:
Published in | The New England journal of medicine Vol. 382; no. 7; pp. 622 - 631 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
Massachusetts Medical Society
13.02.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Among patients with severe antineutrophil cytoplasmic antibody–associated vasculitis, plasma exchange did not reduce the incidence of death or end-stage kidney disease. A reduced-dose regimen of oral glucocorticoids was noninferior to a standard-dose regimen with respect to death or ESKD. |
---|---|
Bibliography: | PMCID: PMC7325726 |
ISSN: | 0028-4793 1533-4406 1533-4406 |
DOI: | 10.1056/NEJMoa1803537 |